Emmanouil S Brilakis, MD, PhD
Minneapolis Heart Institute and Foundation/ Abbott Northwestern Hospital-Allina Health · University of Texas Southwestern Medical Center · North Texas Veterans Healthcare System
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Emmanouil S Brilakis, MD, PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 12:02 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03542110 · The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot TrialMinneapolis Heart Institute Foundation · terminated · Saphenous Vein Graft Atherosclerosis · study chair
- N/ANCT02837562 · Risk of Radiation-induced Cataracts Among Interventional Cardiology StaffUniversity of Texas Southwestern Medical Center · withdrawn · Cataract · principal investigator
- N/ANCT02819531 · Efficacy CompariSon of Pre-stenting Atherectomy Versus Scoring ballooN for calcifieD Coronary Lesions Coronary LesionsNorth Texas Veterans Healthcare System · unknown · Atherosclerosis, Coronary Artery Disease · study chair
- N/ANCT02788929 · Increasing Exercise Adherence After Percutaneous Coronary Intervention With the Fitbit Charge HR DeviceNorth Texas Veterans Healthcare System · unknown · Acute Coronary Syndrome · study chair
- N/ANCT02784418 · The SHINE-CTO TrialMinneapolis Heart Institute Foundation · withdrawn · Coronary Artery Disease, Chronic Total Occlusion of Coronary Artery, Percutaneous Transluminal Coronary Angioplasty · study chair
- Ph4NCT02601664 · Randomized-controlled Trial of a Combined vs. Conventional Percutaneous Intervention for Near-Infrared Spectroscopy Defined High-Risk Native Coronary Artery LesionsNorth Texas Veterans Healthcare System · terminated · Arteriosclerosis, Near-infrared Spectroscopy, Peri-procedural Myocardial Infarction · study chair
- Ph4NCT02510547 · Comparison of a CrossBoss First Versus Standard Wire Escalation Strategy for Crossing Coronary Chronic Total Occlusion: the "CrossBoss First" TrialNorth Texas Veterans Healthcare System · completed · Arteriosclerosis, Coronary Artery Disease, Myocardial Ischemia · study chair
- N/ANCT02265146 · ORACLE-NIRS: Lipid cORe Plaque Association With CLinical Events: a Near-InfraRed Spectroscopy StudyUniversity of Texas Southwestern Medical Center · withdrawn · Coronary Atherosclerosis · principal investigator
- N/ANCT02061436 · Prospective Global Registry for the Study of Chronic Total Occlusion InterventionMinneapolis Heart Institute Foundation · recruiting · Coronary Artery Disease · principal investigator
- Ph4NCT01632670 · Functional Change in Endothelium After Cardiac cAtheterization, With and Without Music TherapyEmmanouil Brilakis · completed · Coronary Artery Disease, Endothelial Dysfunction · principal investigator
- Ph3NCT01510353 · Effect of a Real Time Radiation Monitoring Device on Radiation Exposure During Cardiac CatheterizationNorth Texas Veterans Healthcare System · completed · Radiation Monitoring, Radiation Protection · study chair
- Ph3NCT01446263 · RADIAL Versus Femoral Access for Coronary Artery Bypass Graft Angiography and Intervention (RADIAL-CABG) TrialNorth Texas Veterans Healthcare System · completed · Vascular Access Complication · principal investigator
- Ph4NCT01288105 · Use of Optical Coherence Tomography to Determine the Optimal Management of Patients With Drug-eluting Stents Who Need Non-cardiac SurgeryNorth Texas Veterans Healthcare System · terminated · Coronary Stent Occlusion · principal investigator
- Ph2NCT01221402 · Effect of Extended-Release Niacin on Saphenous Vein Graft AtherosclerosisNorth Texas Veterans Healthcare System · completed · Aortocoronary Saphenous Vein Bypass Graft Atherosclerosis, Intermediate Saphenous Vein Graft Lesions · principal investigator
- Ph4NCT01121224 · Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft AngioplastyVA Office of Research and Development · completed · Saphenous Vein Graft Atherosclerosis
- Ph4NCT01012869 · AngiographiC Evaluation of the Everolimus-Eluting Stent in Chronic Total Occlusions - the ACE-CTO StudyNorth Texas Veterans Healthcare System · completed · Coronary Occlusions · principal investigator
- Ph4NCT00911976 · Study of the Xience V Everolimus-eluting Stent in Saphenous Vein Graft LesionsNorth Texas Veterans Healthcare System · completed · Coronary Artery Bypass, Atherosclerosis · principal investigator
- N/ANCT00827853 · Study Comparing Two Methods of Expanding Stents Placed in Legs of Diabetics With Peripheral Vascular DiseaseNorth Texas Veterans Healthcare System · completed · PERIPHERAL VASCULAR DISEASE · study director
- N/ANCT00781573 · Study of Optimal Clopidogrel Duration in Patients Receiving Drug Eluting Stents (SCORE Trial)North Texas Veterans Healthcare System · completed · Myocardial Infarction · study director
- Ph3NCT00247208 · The SOS (Stenting Of Saphenous Vein Grafts) TrialNorth Texas Veterans Healthcare System · completed · Coronary Artery Bypass, Arteriosclerosis · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 12:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
NIH grants that fund their trials
These grant numbers are on the registry records of the trials above. They fund the trial, often through a cooperative group or network, and their principal investigator is usually someone else.
- Effect of Extended-Release Niacin on Saphenous Vein Graft AtherosclerosisR01HL102442 · NHLBI · UT SOUTHWESTERN MEDICAL CENTER · PI Emmanouil Brilakis · fiscal years 2010 to 2013Named on NCT01221402
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.